India, June 12 -- The funds will be used to boost customer outreach, secure IP rights, scale infrastructure, and grow the core team and to revolutionise healthcare through gut microbiome science

Iom Bioworks, a deep science company pioneering microbiome-focused healthcare, has secured $4 Cr seed round funding led by InflexionPoint Ventures (IPV). The capital will be leveraged for marketing, securing intellectual property claims, strengthening core infrastructure and scaling scientific and commercial teams.

"Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, im...